+ 33 1 46 99 68 20

 

A portfolio of essential medicines

Benzylpenicillin benzathine

Dosages and presentations

Benzylpenicillin benzathine 1.2 MIU. Powder for suspension for injection. Box of 1 vial.
Benzylpenicillin benzathine 2.4 MIU. Powder for suspension for injection. Box of 1 vial.
p

Product information - Patient information leaflet

Active ingredient

Benzathine benzylpenicillin

Marketing

United Kingdom (MA holder: Brancaster)

Product news

This information is intended for healthcare professionals.

Our therapeutic areas

and our main products

Infectiology

Amikacin

Aztreonam

Amoxicillin

Xyllomac®

(France)

Delamoxyle®

(Belgium - Luxembourg)

Delamoxyl®

(Switzerland)

Amoxicillin and clavulanic acid

Benzathine benzylpenicillin

Extencilline®

(France - Switzerland)

Extencin®

(Netherlands)

Benzylpenicillin benzathine

(United Kingdom)

Oxacillin

Istopen®

(France)

Penstapho®

(Italy)

Prostaphlin®

(Czech Republic)

Central nervous system

Lithium carbonate
Tropatépine hydrochloride
Pipotiazine palmitic ester
Lorazepam

Other

Histamine dihydrochloride
Pipobroman
N-acetylcysteine
Some of our products may be available internationally through our distributors, under different trade names. Please contact us to find out more.

REQUEST MEDICAL INFORMATION - REPORT AN ADVERSE EVENT

To request medical information on Delbert Pharma products or report an adverse event,
please write to pharmacovigilance@delbert.fr or contact us on + 33 1 46 99 68 20.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.